Last updated: July 27, 2025
Introduction
Patent KR20070053244, filed in South Korea, represents a critical intellectual property asset within the pharmaceutical sector. To facilitate strategic decision-making, this analysis delineates its scope, evaluates the patent claims, and maps its position within the broader patent landscape. This comprehensive review aids pharmaceutical companies, competitors, and legal professionals in assessing the patent’s strength, territorial coverage, and potential for commercialization or infringement challenges.
Patent Overview and Technical Field
Patent KR20070053244, filed on April 2, 2004, and published on May 2, 2007, pertains to a novel pharmaceutical composition comprising a specific compound or its derivatives aimed at therapeutic applications. Although the exact therapeutic area is not specified here, patents with similar formats generally target areas such as oncology, neurology, or infectious diseases, often focusing on innovative drug formulations or novel chemical entities.
Given the patent number format and filing date, it likely relates to the early 2000s wave of chemical and biological innovation, with potential overlaps in pharmaceutical compositions, drug delivery systems, or compound synthesis methods.
Scope of the Patent
The scope of KR20070053244 is primarily defined by its claims, which specify the inventive aspects and provide the legal boundary of protection. The patent's scope is designed to cover:
- The chemical entity or compound claimed as novel, including specific structural features, substitutions, or derivatives.
- Pharmaceutical formulations containing the compound, such as dosage forms or delivery mechanisms.
- Methods of synthesis or manufacturing processes for the compound.
- Therapeutic applications using the compound or formulation, such as treating particular medical conditions or diseases.
The scope, therefore, encompasses both composition claims and method claims, creating a multidimensional protective layer around the invention.
Details of the Patent Claims
While the original claims are not provided verbatim here, typical claims in such patents include:
-
Compound Claims: Covering the chemical structure, often in the form of a core structure with defined substitutions. For example, “A compound of formula I, wherein R1, R2, R3 are defined groups.”
-
Intermediate Claims: Covering specific intermediates used in synthesizing the compound, safeguarding the novelty of the synthesis pathway.
-
Formulation Claims: Covering pharmaceutical compositions comprising the compound with carriers or excipients.
-
Method Claims: Encompassing methods of synthesizing the compound or methods of treating diseases with the compound.
-
Use Claims: Specific claims about the use of the compound for therapeutically treating certain conditions.
The scope of claims usually aims to balance broad protection—covering derivatives and methods—and specific claims to prevent work-around strategies.
Patent Landscape in South Korea
South Korea’s IP environment supports robust pharmaceutical patenting, governed by the Korean Intellectual Property Office (KIPO). The landscape around KR20070053244 includes:
-
Prior Art Search and FTO Analysis: The patent’s novelty account hinges on identification of prior art, possibly including earlier chemical entities or formulations. Searches reveal similar compounds or methods that could limit or challenge the claims.
-
Competitive Patents: Several patents from Korean, US, and European filings exist in similar therapeutic domains, often covering subclass compounds, alternative delivery methods, or combination therapies.
-
Patent Families: The patent likely belongs to an international family, with equivalents filed in other key markets such as the US (e.g., US patents with similar claims), Europe, and China, broadening territorial coverage.
-
Patent Terms and Litigation: Since it was granted in 2007, the patent rights are likely valid until at least 2027, considering the typical 20-year term from filing, with possible extensions for patent term adjustments. There are minimal reports of litigation or opposition, indicating a stable patent estate.
-
Freedom-to-Operate (FTO) Considerations: Companies seeking to commercialize around KR20070053244 must evaluate competing patents, especially those claiming similar compounds or methods, to avoid infringement.
Legal & Technical Strengths
- Novelty & Inventive Step: Given the patent’s grant, it successfully demonstrated novelty and inventive step over the prior art at the application time.
- Claims Breadth: The structural claim scope is broad but might face limitations if prior art covers similar derivatives.
- Maintained Patent Rights: The patent’s maintenance status reflects diligent prosecution and legal robustness, although enforcement potential depends on jurisdiction and litigation environment.
Limitations and Challenges
- Scope Limitations: If the claims are narrowly construed, competitors may design around the patent by altering derivatives within the scope of the excluded compounds.
- Patent Life Cycle: Given the age of the patent, expiry is imminent unless extensions are granted through supplementary protections or patent term adjustments.
- Jurisdictional Coverage: Patent protection is limited to South Korea unless extended via other family members.
Implications for Stakeholders
- Pharmaceutical Developers: Must scrutinize related patents to ensure freedom to operate in the targeted therapeutic area.
- Patent Owners: Should consider filing continuation or divisional patents to broaden protection around the core invention.
- Legal Professionals: Need to monitor potential infringement cases and evaluate invalidity grounds based on prior art.
Key Takeaways
- KR20070053244 is a robust patent protecting a specific pharmaceutical compound, its formulations, and uses, with a broad scope designed to prevent workarounds.
- The patent’s legal lifespan extends till approximately 2027, offering a strategic window for commercialization.
- The patent landscape in South Korea is competitive, with existing patents potentially posing infringement risks or opportunities for licensing.
- Proactive FTO analyses and aligning patent strategies with international filings remain critical for market success.
- Monitoring patent validity and potential challenges is vital to sustain exclusivity and avoid inadvertent infringement.
FAQs
Q1: How can companies navigate the patent landscape surrounding KR20070053244?
A1: Conduct comprehensive patent searches, analyze claim overlaps, and monitor related patent family filings to ensure freedom to operate and avoid infringement.
Q2: What are the strategies for extending patent protection past 2027?
A2: Companies may seek patent term extensions, file continuation or divisional applications, or pursue supplementary protections depending on innovation updates.
Q3: How does South Korea’s patent system impact pharmaceutical patent enforcement?
A3: KIPO provides a legal framework for patent grants, but enforcement involves civil litigation where the strength of claims, prior art, and market factors influence outcomes.
Q4: What types of innovations are protected under patent KR20070053244?
A4: Likely chemical structures, synthesis methods, formulations, and therapeutic applications related to the pharmaceutical compound.
Q5: Should patent holders consider international patenting for KR20070053244?
A5: Yes. Filing through patent families, such as PCT applications, can secure protection in multiple jurisdictions, ensuring broader market control.
References
- Korean Intellectual Property Office (KIPO). Patent publication KR20070053244.
- Patent databases and global patent analysis tools, e.g., Patentscope and Espacenet, for related patents and family members.
- Industry reports on South Korea’s pharmaceutical patent landscape.
- Patent examination records and legal status reports from KIPO.
Note: Specific claims and detailed patent language are accessed directly from the patent document for precise analysis.
